New antibody aims to control lymphoma without chemo side effects
NCT ID NCT03322865
First seen May 13, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tests a drug called obinutuzumab in 56 people with newly diagnosed marginal zone lymphoma who cannot have or did not respond to local therapy. The goal is to see if this antibody can shrink tumors and control the disease without the harsh side effects of chemotherapy. Participants receive the drug alone, and doctors check how many achieve complete remission after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Augusta-Kranken-Anstalt gGmbH
Bochum, 44791, Germany
-
Gemeinschaftspraxis für Hämatologie und Onkologie
Münster, 48149, Germany
-
Institut für Versorgungsforschung GbR
Koblenz, 56068, Germany
-
Klinikum Passau
Passau, 94032, Germany
-
University Hospital Essen
Essen, 45147, Germany
-
University Hospital Halle
Halle, 06120, Germany
-
University Hospital Mainz
Mainz, 55101, Germany
-
University Hospital Münster
Münster, 48149, Germany
-
University Hospital Ulm
Ulm, 89081, Germany
-
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
-
Universitätsklinikum Mannheim
Mannheim, 68167, Germany
-
Universitätsmedizin Georg-August-University
Göttingen, 37075, Germany
Conditions
Explore the condition pages connected to this study.